Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $678.93 million as of August 14, 2025. Its market cap has increased by 259.98% in one year.

Market Cap

678.93M

Enterprise Value

628.72M

1-Year Change

259.98%

Ranking

#2790

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $678.93M, an increase of 166.35%. That is a compound annual growth rate of 4.04%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	619.20M	108.98%
Dec 31, 2024	296.30M	17.21%
Dec 29, 2023	252.80M	-2.51%
Dec 30, 2022	259.30M	-42.78%
Dec 31, 2021	453.20M	-23.37%
Dec 31, 2020	591.40M	64.87%
Dec 31, 2019	358.70M	-6.42%
Dec 31, 2018	383.30M	-32.57%
Dec 29, 2017	568.40M	141.36%
Dec 30, 2016	235.50M	-12.19%
Dec 31, 2015	268.20M	34.57%
Dec 31, 2014	199.30M	-20.02%
Dec 31, 2013	249.20M	-55.93%
Dec 31, 2012	565.50M	0.60%
Dec 30, 2011	562.10M	43.14%
Dec 31, 2010	392.70M	-20.31%
Dec 31, 2009	492.80M	68.36%
Dec 31, 2008	292.70M	-62.86%
Dec 31, 2007	788.20M	164.67%
Dec 29, 2006	297.80M	47.43%
Dec 30, 2005	202.00M	-57.71%
Dec 31, 2004	477.70M	68.26%
Dec 31, 2003	283.90M	465.54%
Dec 31, 2002	50.20M	-71.28%
Dec 31, 2001	174.80M	-51.24%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	573.90B
Johnson & Johnson	414.93B
AbbVie	349.76B
UnitedHealth Group	235.95B
AstraZeneca	229.47B
Novartis AG	228.69B
Abbott Laboratories	225.84B
Novo Nordisk	222.88B

Market Cap Rankings